FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Inox CVA IPO and Mukka Proteins IPO.
Inox CVA IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Mukka Proteins IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Inox CVA IPO | Mukka Proteins IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | ICICI Securities Limited Axis Capital Limited |
Fedex Securities Pvt Ltd |
Registrar | Kfin Technologies Limited | Cameo Corporate Services Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Inox CVA IPO is up to ₹1,459.32 Cr whereas the issue size of the Mukka Proteins IPO is up to ₹224.00 Cr. The final issue price of Inox CVA IPO is ₹660.00 per share and of Mukka Proteins IPO is ₹28.00 per share.
Inox CVA IPO | Mukka Proteins IPO | |
---|---|---|
Face Value | ₹2 per share | ₹1 per share |
Issue Price (Lower) | ₹627.00 per share | ₹26.00 per share |
Issue Price (Upper) | ₹660.00 per share | ₹28.00 per share |
Issue Price (Final) | ₹660.00 per share | ₹28.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 22 shares | 535 shares |
Fresh Issue Size | 8,00,00,000 shares | |
Fresh Issue Size (Amount) | up to ₹224.00 Cr | |
OFS Issue Size | 2,21,10,955 shares | |
OFS Issue Size (Amount) | up to ₹1,459.32 Cr | |
Issue Size Total | 2,21,10,955 shares | 8,00,00,000 shares |
Issue Size Total (Amount) | up to ₹1,459.32 Cr | up to ₹224.00 Cr |
Inox CVA IPO opens on Dec 14, 2023, while Mukka Proteins IPO opens on Feb 29, 2024. The closing date of Inox CVA IPO and Mukka Proteins IPO is Dec 18, 2023, and Mar 04, 2024, respectively.
Inox CVA IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Bid Date | Dec 13, 2023 | Feb 28, 2024 |
Issue Open | Dec 14, 2023 | Feb 29, 2024 |
Issue Close | Dec 18, 2023 | Mar 04, 2024 |
Basis Of Allotment (Tentative) | Dec 19, 2023 | Mar 05, 2024 |
Initiation of Refunds (Tentative) | Dec 20, 2023 | Mar 06, 2024 |
Credit of Share (Tentative) | Dec 20, 2023 | Mar 06, 2024 |
Listing date (Tentative) | Dec 21, 2023 | Mar 07, 2024 |
Anchor Lockin End date 1 | Jan 18, 2024 | Apr 04, 2024 |
Anchor Lockin End date 2 | Mar 18, 2024 | Jun 03, 2024 |
Inox CVA IPO P/E ratio is 39.22, as compared to Mukka Proteins IPO P/E ratio of 12.96.
Inox CVA IPO | Mukka Proteins IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Inox India Limited Financial Information (Restated Consolidated)Inox India Limited's revenue increased by 22.46% and profit after tax (PAT) rose by 17.02% between the financial year ending with March 31, 2023 and March 31, 2022.
|
Mukka Proteins Limited Financial Information (Restated Consolidated)Mukka Proteins Limited's revenue increased by 52.52% and profit after tax (PAT) rose by 84.07% between the financial year ending with March 31, 2023 and March 31, 2022.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.30% | 100% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 75.46% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 39.22 | 12.96 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹5990.39 Cr. | ₹840.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 27.79%% | 36.71%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 36.53%% | 17.62%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 1.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹16.83 | ₹2.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 27.79%% | 34.19%% |
In the Inox CVA IPO retail investors (RII) are offered 77,38,835 shares while in Mukka Proteins IPO retail investors are offered 77,38,835 shares. Qualified institutional buyers (QIB) are offered 44,22,191 shares in Inox CVA IPO and 1,60,00,435 shares in Mukka Proteins IPO.
Inox CVA IPO | Mukka Proteins IPO | |
---|---|---|
Anchor Investor Reserveration | 66,33,285 shares | 2,39,99,565 shares |
Market Maker Reserveration | ||
QIB | 44,22,191 shares | 1,60,00,435 shares |
NII | 33,16,644 shares | 1,20,00,000 shares |
RII | 77,38,835 shares | 2,80,00,000 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,54,77,670 shares | 5,60,00,435 shares |
Inox CVA IPO subscribed 61.28x in total, whereas Mukka Proteins IPO subscribed 136.99x.
Inox CVA IPO | Mukka Proteins IPO | |
---|---|---|
QIB (times) | 147.80x | 189.28x |
NII (times) | 53.20x | 250.39x |
Big NII (times) | 56.55x | 254.15x |
Small NII (times) | 46.52x | 242.86x |
RII (times) | 15.30x | 58.52x |
Employee (times) | ||
Other (times) | ||
Total (times) | 61.28x | 136.99x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|